SCHEMBL9196396

SCHEMBL9196396

NC(=O)c1cc(C(=O)c2ccccc2)ccc1[N+](=O)[O-]

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.68
VCAM1 P19320 2/20 0.60
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
ALDH1A1 P00352 1/20 0.48
BCL2L1 Q07817 1/20 0.47
POLB P06746 1/20 0.46
CASP6 P55212 1/20 0.46
CDC25B P30305 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CES2 O00748 2/20 0.46
CES1 P23141 1/20 0.46
PARP1 P09874 1/20 0.45
KDM4E B2RXH2 1/20 0.45
GLA P06280 1/20 0.45
CYP19A1 P11511 1/20 0.44
HPSE Q9Y251 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6806849 0.88 VCAM1 (0.64) MAPK1VCAM1LMNAGAAALDH1A1
SCHEMBL9199250 0.88 MAPK1 (0.68) MAPK1VCAM1ALDH1A1POLBCASP6
SCHEMBL17973446 0.85 MAPK1 (0.64) MAPK1VCAM1LMNAALDH1A1POLB
SCHEMBL9198295 0.85 MAPK1 (0.64) MAPK1VCAM1LMNAALDH1A1POLB
SCHEMBL6553684 0.84 PARP1 (0.62) LMNAGAAALDH1A1POLBCASP6
SCHEMBL27711812 0.84 MAPK1 (0.62) MAPK1VCAM1LMNAALDH1A1POLB
SCHEMBL11014183 0.82 MAPK1 (0.73) MAPK1VCAM1LMNAALDH1A1POLB
SCHEMBL11014246 0.81 MAPK1 (1.00) MAPK1VCAM1LMNAALDH1A1POLB
SCHEMBL9760868 0.81 MAPK1 (0.59) MAPK1VCAM1GAAALDH1A1POLB
Carbamic Acid SCHEMBL28316763 0.81 MAPK1 (0.67) MAPK1VCAM1GAAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036002-C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
CN-1106004-A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
CN-1106005-A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed
CN-1042912-A (1H-oxazol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-06-13 CN disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed